NOVAVAX INC (NVAX) Net margin 2016–2025
NOVAVAX INC (NVAX) net profit margin by fiscal year — reported net income divided by reported revenue.
39.2%FY2025 · since FY2016: -1823.5% → 39.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 39.2% | +66.7 pp |
| FY2024 | -27.5% | +27.9 pp |
| FY2023 | -55.4% | -22.2 pp |
| FY2022 | -33.2% | +118.9 pp |
| FY2021 | -152.1% | -64.2 pp |
| FY2020 | -87.9% | +623.1 pp |
| FY2019 | -711.0% | -172.2 pp |
| FY2018 | -538.8% | +50.6 pp |
| FY2017 | -589.5% | +1234.1 pp |
| FY2016 | -1823.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More NVAX financial trends
NVAX RevenueNVAX Net incomeNVAX Gross profitNVAX Gross marginNVAX Operating incomeNVAX Operating marginNVAX Operating cash flowNVAX Free cash flowNVAX Capital expendituresNVAX Return on equityNVAX Stock buybacksNVAX Dividends paidNVAX Total assetsNVAX Total liabilitiesNVAX Shareholders’ equityNVAX overview →